{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:29:19Z","timestamp":1790976559209,"version":"4.1.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Spine"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1097\/00007632-199307000-00007","type":"journal-article","created":{"date-parts":[[2006,10,10]],"date-time":"2006-10-10T05:25:49Z","timestamp":1160457949000},"page":"1160-1172","source":"Crossref","is-referenced-by-count":79,"title":["Report of a Prospective Study of 250 Patients Enrolled in Food and Drug Administration Clinical Trials"],"prefix":"10.1097","volume":"18","author":[{"given":"Arthur D.","family":"Steffee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Brantigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007632-199307000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:04:56Z","timestamp":1785863096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007632-199307000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":0,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.1097\/00007632-199307000-00007","relation":{},"ISSN":["0362-2436"],"issn-type":[{"value":"0362-2436","type":"print"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}